Why the study?
Does benazepril hydrochloride improve acute hemodynamics in patients with chronic congestive heart failure?
Does benazepril hydrochloride improve acute hemodynamics in patients with chronic congestive heart failure?
A single oral dose of benazepril hydrochloride produces significant and sustained hemodynamic improvements for up to 24 hours in patients with severe chronic heart failure.
Answers are grounded in this paper and cite their sources.
May support acute hemodynamic effects of benazepril in severe chronic HF; leaves open outcome confirmation in randomized trials.
Benazepril hydrochloride is a nonsulfhydryl, long-acting angiotensin-converting enzyme inhibitor that is orally effective. This study was designed to determine the acute hemodynamic effects of this agent in patients with chronic congestive heart failure. Twenty-six patients with New York Heart Association class III or IV congestive heart failure and left ventricular ejection fractions less than 35%, cardiac indexes less than 2.1 L/min/m2, and pulmonary artery wedge pressures greater than 12 mm Hg were given 2 or 5 mg benazepril hydrochloride. All does produced significant (p less than 0.05) increases in cardiac output (26.7% to 31.6% above control) and heart rate (5.4% to 11.2% above control) and decreases in systemic (27.1% to 32.0% below control) and pulmonary (34.8% to 55.5% below control) vascular resistances, mean pulmonary (25.3% to 30.3% below control) and systemic (13.4% to 18.5% below control) arterial pressures, and pulmonary artery wedge pressure (46.9% to 51.1% below control). Twenty-four hours after an initial dose, systemic vascular resistance and pulmonary artery wedge pressures remained below control levels. Angiotensin-converting enzyme activity fell by 67.8% +/- 6.4%, with a 15.8% +/- 7.6% decline in aldosterone levels. Thus benazepril hydrochloride is an effective angiotensin-converting enzyme inhibitor that produces hemodynamic effects that persist for 24 hours after a single oral dose.
No takes yet. Share an insight, caveat, or question.
Insel et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: